Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy Kohlmann

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
JCO Precision Oncology|September 14, 2020
Lynch Syndrome and Breast Cancer Risk: Weighing the DataWendy Kohlmann
Hematology. American Society of Hematology. Education Program|December 4, 2016
Discussing and managing hematologic germ line variantsWendy Kohlmann, Joshua D Schiffman
Blood|November 25, 2016
Discussing and managing hematologic germ line variantsWendy Kohlmann, Joshua D Schiffman
Journal of the National Comprehensive Cancer Network : JNCCN|September 22, 2009
The genetics of hereditary non-polyposis colorectal cancerStephen B Gruber, Wendy Kohlmann
Digestion|October 20, 2007
Can we identify the high-risk patients to be screened? A genetic approachAmanda Gammon, Wendy Kohlmann, Randall Burt
JOP : Journal of the Pancreas|May 6, 2010
Identification and screening of individuals at increased risk for pancreatic cancer with emphasis on known environmental and genetic factors and hereditary syndromesDavid Chu, Wendy Kohlmann, Douglas G Adler
Oncology (Williston Park, N.Y.)|April 25, 2006
Genetics of colorectal cancerJoanne M Jeter, Wendy Kohlmann, Stephen B Gruber
Frontiers in Oncology|April 1, 2022
Non-Melanoma Skin Cancers and Other Cutaneous Manifestations in Bone Marrow Failure Syndromes and Rare DNA Repair DisordersJennie Vagher, Amanda Gammon, Wendy Kohlmann, et al.
Frontiers in Oncology|April 4, 2022
Considerations for Germline Testing in Melanoma: Updates in Behavioral Change and Pancreatic Surveillance for Carriers of <i>CDKN2A</i> Pathogenic VariantsKristen Pauley, Ambreen Khan, Wendy Kohlmann, et al.
Best Practice & Research. Clinical Gastroenterology|May 6, 2009
Hamartomatous polyposis syndromesAmanda Gammon, Kory Jasperson, Wendy Kohlmann, et al.
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
JCO Precision Oncology|September 14, 2020
Lynch Syndrome and Breast Cancer Risk: Weighing the DataWendy Kohlmann
Hematology. American Society of Hematology. Education Program|December 4, 2016
Discussing and managing hematologic germ line variantsWendy Kohlmann, Joshua D Schiffman
Blood|November 25, 2016
Discussing and managing hematologic germ line variantsWendy Kohlmann, Joshua D Schiffman
Journal of the National Comprehensive Cancer Network : JNCCN|September 22, 2009
The genetics of hereditary non-polyposis colorectal cancerStephen B Gruber, Wendy Kohlmann
Digestion|October 20, 2007
Can we identify the high-risk patients to be screened? A genetic approachAmanda Gammon, Wendy Kohlmann, Randall Burt
JOP : Journal of the Pancreas|May 6, 2010
Identification and screening of individuals at increased risk for pancreatic cancer with emphasis on known environmental and genetic factors and hereditary syndromesDavid Chu, Wendy Kohlmann, Douglas G Adler
Oncology (Williston Park, N.Y.)|April 25, 2006
Genetics of colorectal cancerJoanne M Jeter, Wendy Kohlmann, Stephen B Gruber
Frontiers in Oncology|April 1, 2022
Non-Melanoma Skin Cancers and Other Cutaneous Manifestations in Bone Marrow Failure Syndromes and Rare DNA Repair DisordersJennie Vagher, Amanda Gammon, Wendy Kohlmann, et al.
Frontiers in Oncology|April 4, 2022
Considerations for Germline Testing in Melanoma: Updates in Behavioral Change and Pancreatic Surveillance for Carriers of <i>CDKN2A</i> Pathogenic VariantsKristen Pauley, Ambreen Khan, Wendy Kohlmann, et al.
Best Practice & Research. Clinical Gastroenterology|May 6, 2009
Hamartomatous polyposis syndromesAmanda Gammon, Kory Jasperson, Wendy Kohlmann, et al.
Pageof 13